-96.5%
MSTU vs GSK
+21.8%
-118.3%
-99.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -19.7% | -0.1% | -19.6% | -19.7% |
| 7D | -53.2% | -5.3% | -47.9% | -53.9% |
| 30D | -76.5% | -3.7% | -72.8% | -76.7% |
| 3M | -62.8% | -7.3% | -55.5% | -63.4% |
| 6M | -86.6% | -4.2% | -82.3% | -86.7% |
| YTD | -89.1% | +0.9% | -90.0% | -88.6% |
| 1Y | -92.5% | +7.3% | -99.8% | -91.9% |
| All | -96.5% | +21.8% | -118.3% | -95.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling